2025
|
Invention
|
Surface-modified viral particles and modular viral particles.
This invention relates generally t... |
2024
|
Invention
|
Tissue specific anellovector delivery. Anelloviridae family vectors (e.g., anellovectors) can be ... |
|
Invention
|
Anellovectors for delivery of effectors to the central nervous system.
This invention relates ge... |
|
Invention
|
Anellovectors for delivery of effectors to the central nervous system. This invention relates gen... |
|
Invention
|
Conjugates and methods of using the same.
Disclosed are conjugates including a recognition eleme... |
|
Invention
|
Anellovirus constructs comprising recombination sites and cross-packaging of anellovector particl... |
|
Invention
|
Genetic switches and their use in treating cancer.
In certain aspects, the disclosure relates to... |
|
Invention
|
Genetic switches and their use in treating cancer. In certain aspects, the disclosure relates to ... |
2023
|
Invention
|
Active agents and methods of their use for the treatment of metabolic disorders and nonalcoholic ... |
|
Invention
|
Nucleic acid molecules encoding trif and additional polypeptides and their use in treating cancer... |
|
Invention
|
Nucleic acid molecules encoding trif and additionalpolypeptides and their use in treating cancer.... |
|
Invention
|
Combination therapies comprising myc modulators and checkpoint inhibitors. The present disclosure... |
|
Invention
|
Formulations for modulating myc expression. The present disclosure relates to compositions and me... |
|
Invention
|
Combination therapies comprising myc modulation |
|
Invention
|
Combination therapies comprising myc modulation. The present disclosure relates to combination th... |
|
Invention
|
Multibiotic agents and methods of using the same.
Multibiotic agents are disclosed. The multibio... |
|
Invention
|
Compositions comprising modified anellovirus capsid proteins and uses thereof. This invention rel... |
|
Invention
|
Compositions comprising modified anellovirus capsid proteins and uses thereof |
|
Invention
|
Cxcl-modulating compositions and methods.
The present disclosure relates to expression repressor... |
|
Invention
|
Cxcl-modulating compositions and methods. The present disclosure relates to expression repressors... |
|
Invention
|
Cxcl-modulating compositions and methods |
|
Invention
|
Novel anelloviridae family vector compositions and methods. This invention relates generally to A... |
|
Invention
|
Novel anelloviridae family vector compositions and methods. In an approach to generating playlist... |
|
Invention
|
Compositions for facilitating membrane fusion and uses thereof.
In some aspects, fusosome compos... |
2022
|
Invention
|
Surface-modified viral particles and modular viral particles. This invention relates generally to... |
|
Invention
|
Novel anellovector compositions and methods.
This invention relates generally to Anelloviridae f... |
|
Invention
|
Novel anellovector compositions and methods. This invention relates generally to Anelloviridae fa... |
|
Invention
|
Compositions comprising curons and uses thereof.
This invention relates generally to pharmaceuti... |
|
Invention
|
Immune cells engineered to promote thanotransmission and uses thereof.
In certain aspects, the d... |
|
Invention
|
Anellovectors and methods of use.
This invention relates generally to anellovectors and composit... |
|
Invention
|
Methods and compositions for modulating gene expression.
The present disclosure provides composi... |
|
Invention
|
Hybrid aav-anellovectors.
This invention relates generally to compositions for making and admini... |
2021
|
Invention
|
Use of cell turnover factors for increasing tissue regeneration.
The disclosure provides methods... |
|
Invention
|
Compositions and methods for modulating myc expression.
The present disclosure relates to compos... |
|
Invention
|
Chicken anemia virus (cav)-based vectors.
This invention relates generally to compositions for m... |
|
Invention
|
Compositions and methods for inhibiting the expression of multiple genes.
The present disclosure... |
|
Invention
|
Compositions and methods for inhibiting gene expression.
The present disclosure relates to expre... |
|
Invention
|
Methods and compositions for producing viral fusosomes.
The present disclosure provides, at leas... |
|
Invention
|
Viruses engineered to promote thanotransmission and their use in treating cancer.
In certain asp... |
|
Invention
|
Methods of identifying and characterizing anelloviruses and uses thereof.
This invention relates... |
|
Invention
|
Tandem anellovirus constructs.
This invention relates generally to compositions for making anell... |
|
Invention
|
Baculovirus expression systems.
This invention relates generally to compositions for making anel... |
2020
|
Invention
|
Combination anti-cancer therapies with inducers of iron-dependent cellular disassembly.
The inve... |
2019
|
Invention
|
Anellosomes for delivering secreted therapeutic modalities.
This invention relates generally to ... |
|
Invention
|
Compositions and methods for compartment-specific cargo delivery.
Fusosome compositions and meth... |
2017
|
Invention
|
Methods of altering a target nucleotide sequence with an rna-guided nuclease and a single guide r... |